MEDvidi Review 2026
Reviewed August 5, 2026 · Brand-name FDA-approved only — no compounded semaglutide or tirzepatide offered
Visit MEDvidi WebsiteOverview
MEDvidi, Inc. brings a proper clinical formulary to online weight management rather than the two-product menu most GLP-1 platforms offer. Its medication list runs to ten options: semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro, Zepbound), liraglutide (Saxenda, Victoza), dulaglutide (Trulicity), plus non-GLP-1 alternatives including phentermine-topiramate (Qsymia), naltrexone-bupropion (Contrave), phentermine, topiramate, metformin and orlistat. All are FDA-approved — MEDvidi does not offer compounded products. That breadth matters because a patient who cannot tolerate or afford a GLP-1 has real alternatives instead of being turned away. Eligibility is published: BMI 30 or above, or 27 or above with weight-related conditions. Assessment is thorough, including a mental health examination alongside BMI, diet and activity analysis. Pricing is per consultation — $195 introductory, $159 follow-up, or $249 for a package — with medication billed separately and no insurance or HSA/FSA accepted.
Medications Offered
Brand-name or compounded: Brand-name FDA-approved only — no compounded semaglutide or tirzepatide offered
- Semaglutide — Ozempic, Wegovy, Rybelsus (FDA-approved)
- Tirzepatide — Mounjaro, Zepbound (FDA-approved)
- Liraglutide — Saxenda, Victoza (FDA-approved)
- Dulaglutide — Trulicity (off-label for weight)
- Phentermine-topiramate — Qsymia (FDA-approved)
- Naltrexone-bupropion — Contrave (FDA-approved)
- Phentermine — Lomaira, Adipex-P (FDA-approved)
- Topiramate — Topamax (off-label)
- Metformin (off-label)
- Orlistat — Xenical, Alli (FDA-approved)
Consultation Process
Assessment questionnaire
You complete an assessment covering medical history, BMI, diet and activity.
Online video consultation
You meet a provider by video. The introductory consultation is $195, or $249 for a package including a follow-up.
Comprehensive evaluation including mental health
MEDvidi's evaluation includes a mental health examination alongside physical and metabolic assessment — unusual in weight-management telehealth and clinically appropriate given GLP-1 mood considerations.
Prescription to your pharmacy
If appropriate, a prescription for one of ten FDA-approved options is issued. Medication is billed separately by your pharmacy.
Eligibility
- BMI of 30 or above, OR BMI of 27 or above with weight-related conditions such as high cholesterol, hypertension or type 2 diabetes
- Assessed via questionnaire, medical history review, BMI measurement, diet and activity analysis and a mental health examination
- Adults only; standard GLP-1 contraindications apply
- No insurance accepted — cash pay only
Provider Involvement
MEDvidi runs video consultations rather than asynchronous review, and its assessment explicitly includes a mental health examination — a genuinely thoughtful inclusion given documented mood considerations with weight-management medication. Follow-up consultations at $159 are a real ongoing cost, but they represent actual clinical contact rather than a subscription fee.
Lab Requirements
Not published. Because MEDvidi prescribes to your own pharmacy, labs ordered through your insurance would typically be cheaper than telehealth cash-pay arrangements.
Pharmacy Fulfillment
Not published. Because MEDvidi prescribes only FDA-approved medications, fulfilment runs through retail pharmacies dispensing manufacturer product — there is no compounding step and therefore none of the associated quality uncertainty.
Shipping Frequency
Not applicable in the mail-order sense; prescriptions go to your pharmacy on its normal fill schedule.
Membership Fees vs. Medication Fees
Membership fees
None. MEDvidi charges per consultation rather than running a subscription — $195 introductory, $159 follow-up, or $249 for a package of both.
Medication fees
- Introductory consultation: $195
- Introductory plus follow-up package: $249 (saves $105)
- Follow-up consultation: $159
- Medication: billed separately by your pharmacy, cost not published
Cancellation & Refund Policy
Cancellation
Not published. Because there is no subscription, exposure is limited to individual consultations.
Refunds
Not published on the pages we reviewed.
Insurance
MEDvidi states plainly that it does not currently accept insurance. Note that because it prescribes FDA-approved medication to your own pharmacy, your pharmacy benefit may still cover the drug even though it will not cover the consultation.
HSA / FSA
MEDvidi states it does not accept insurance or HSA/FSA. That is unusual — most cash-pay telehealth accepts HSA/FSA cards — and it removes what would otherwise be an effective 20-35% discount for many patients.
See our GLP-1 insurance and HSA/FSA guide for how reimbursement works in practice.
Support Services
- Video consultations with providers
- Mental health examination as part of the weight assessment
- Ten FDA-approved medication options including non-GLP-1 alternatives
- Discounted introductory-plus-follow-up package
- Broader MEDvidi platform covering other conditions
State Availability
Not published. Confirm your state is served before booking a $195 consultation.
Pros
- The broadest FDA-approved weight-management formulary in this review — ten medications
- No compounded products at all
- Publishes clear BMI eligibility criteria
- Transparent per-consultation pricing with a discounted package option
- Comprehensive assessment including a mental health examination
- Offers non-GLP-1 alternatives for patients who cannot use or afford GLP-1s
Cons
- $195 introductory consultation is the most expensive in this review
- No insurance and no HSA/FSA accepted
- Medication cost is entirely separate and not published
- No published state list, lab requirements, pharmacy or refund terms
- Follow-up consultations at $159 add up over a year of treatment
Who MEDvidi May Be Best For
- Patients who want FDA-approved medication and a real formulary choice
- People who cannot tolerate or afford GLP-1s and need alternatives like Contrave or Qsymia
- Patients who want a mental health component in their weight assessment
- Anyone who wants to fill a prescription on their own pharmacy benefit
Limitations
- $195 introductory consultation is the highest in this review
- No insurance and no HSA/FSA accepted
- Medication cost entirely separate and unpublished
- $159 follow-ups accumulate over a year of treatment
- No published state list, labs, pharmacy or refund terms
Reputation & Trust
Prescribing only FDA-approved medication, publishing BMI eligibility criteria, and including a mental health examination in the assessment are all signals of a clinically serious operation rather than a prescription mill. The formulary breadth — including non-GLP-1 options — means MEDvidi can treat patients GLP-1-only platforms would simply decline. The commercial weaknesses are the high consultation price and the refusal of both insurance and HSA/FSA.
What Makes MEDvidi Different
- Ten FDA-approved weight-management medications, including non-GLP-1 options
- No compounded products at all
- Mental health examination included in the assessment
- Published BMI eligibility criteria
- Per-consultation pricing with no subscription
Our Verdict
MEDvidi earns 4/5 for treating obesity as a medical condition with a real formulary rather than a two-product catalogue. Ten FDA-approved options including non-GLP-1 alternatives means a patient who cannot tolerate semaglutide or afford tirzepatide has somewhere to go instead of being declined, and including a mental health examination in the assessment is a clinically thoughtful touch nobody else in this review matches. Published BMI criteria and no compounded product at all round out a serious clinical proposition. The friction is cost: $195 to start and $159 per follow-up, with no insurance and — unusually — no HSA/FSA accepted, so there is no tax-advantaged way to soften it. Strong clinically; expensive administratively.
Alternatives to MEDvidi
Brand-name-only across 50 states with visits from ~$51 and 400+ insurance plans accepted.
Brand-name prescribing at $0-$35 per visit with accepted insurance.
$39 care with published medication pricing from $149/month.
Accepts Medicare and Medicaid with $99 self-pay visits.
Compare more options on our best online GLP-1 providers and cheapest GLP-1 programs pages.
Frequently Asked Questions
Does MEDvidi prescribe compounded semaglutide?
No. MEDvidi's formulary is entirely FDA-approved medications — semaglutide, tirzepatide, liraglutide and dulaglutide alongside non-GLP-1 options such as Qsymia, Contrave, phentermine, topiramate, metformin and orlistat.
What does MEDvidi cost?
Consultations only: $195 introductory, $159 follow-up, or $249 for a package of both. Medication is billed separately by your pharmacy and its cost is not published. MEDvidi does not accept insurance or HSA/FSA.
Why does MEDvidi include a mental health examination?
MEDvidi's stated assessment includes a mental health examination alongside BMI, diet and activity analysis. Mood considerations are clinically relevant with weight-management medication, and very few competitors screen for them at all.
Can I use my insurance for the medication?
MEDvidi does not accept insurance for consultations, but because it prescribes FDA-approved medication to your own pharmacy, your pharmacy benefit may still cover the drug itself. That is a meaningful distinction — the consultation is cash-pay, the medication may not be.
Important Notes & Warnings
- MEDvidi does not accept insurance or HSA/FSA for consultations.
- Consultation fees of $195 and $159 are separate from medication cost, which is not published.
- Ozempic, Mounjaro, Victoza, Trulicity, topiramate and metformin used for weight loss are off-label prescribing.
- No state list, lab requirements, pharmacy or refund terms are published.
- Contraindicated with a personal or family history of medullary thyroid carcinoma or MEN2.
Sources
- MEDvidi weight loss program pages, medvidi.com (accessed August 2026)
- Google Search results collected via Bright Data SERP API, August 2026
Medical Disclaimer
This review is for informational purposes only and is not medical advice, a diagnosis, or a treatment recommendation. GLP-1 medications are prescription drugs with real risks and contraindications. Only a licensed clinician who has evaluated you can decide whether any medication is appropriate. Talk to a healthcare provider before starting, changing, or stopping any treatment, and call emergency services for urgent symptoms.
Facts in this review were compiled from the provider's own public website and public search results as of August 5, 2026. Prices, medication availability, pharmacy partners, and policies change frequently and vary by state — verify everything directly with the provider before purchasing.
This page contains affiliate links. We may earn a commission from qualifying purchases at no additional cost to you.